MidCap Advisors Advises Leading Midwest Psychiatric Care Provider in Its Acquisition by Health Catalyst Capital

Health Catalyst Capital (HCC), a New York-based private equity firm, has acquired a leading provider of psychiatric medical care for elderly and disabled adults located in the Midwest. The deal, announced on July 28, 2026, involves an undisclosed transaction value and was facilitated by MidCap Advisors, which served as the exclusive financial advisor to the target company. This acquisition marks a strategic move for HCC as it seeks to expand its footprint in the healthcare sector, particularly in the area of psychiatric services.

The Midwest-based psychiatric care provider operates a scalable, clinician-led model that serves long-term care facilities and hospitals, delivering high-quality care to a vulnerable patient population. With a commitment to enhancing mental health services for elderly and disabled individuals, the practice has established itself as a leader in the region. The acquisition by HCC is expected to provide the necessary resources and operational expertise to further enhance the practice's capabilities and reach.

Health Catalyst Capital specializes in investing in healthcare services and technology businesses that aim to improve care quality, access, and affordability. The firm leverages its extensive network, which includes over 250 major healthcare and technology enterprises, to identify sustainable investment opportunities. By integrating artificial intelligence into operations and facilitating commercial relationships, HCC aims to drive value creation for its portfolio companies. This acquisition aligns with HCC's strategy to support businesses that prioritize quality care while also expanding their market presence.

The psychiatric care sector is experiencing heightened demand due to an aging population and increased awareness of mental health issues. As healthcare providers adapt to these evolving needs, partnerships and acquisitions like this one are becoming increasingly common. The backing of a private equity firm such as HCC is likely to provide the target company with the necessary capital and strategic guidance to navigate these challenges effectively.

Looking ahead, the acquisition is expected to have broader implications for the healthcare market, particularly in the realm of psychiatric services. As more firms recognize the importance of mental health care, investments in this sector may increase, leading to enhanced service offerings and improved patient outcomes. The collaboration between HCC and the Midwest psychiatric care provider could serve as a model for future transactions in the healthcare space, emphasizing the importance of quality care and operational efficiency in addressing the needs of vulnerable populations.